Anti-Snoring Treatment Market is expected to grow at a significant rate during the forecast period 2019-2025. Snoring is a kind of sleep-disordered breathing that can disrupt healthy and restorative sleep. The problem of snoring is associated with increased risks for other health problems such as obstructive sleep apnea. In addition, people with snoring problems are at increased risk of depression and anxiety, heart disease and stroke, and accidental injury. Global anti-snoring treatment is estimated to grow at a significant rate owing to various factors such as increasing obese population, changing the lifestyle of the people such as tobacco, smoking and alcohol consumption and others. In addition, snoring becomes a common problem with the people at increased age, making geriatric population as one of the factors for the market growth.
Changing the lifestyle of the people contributes significantly to the growth of the market. The trend of smoking, drinking alcohol and ill eating activity is increasing among the people which is a major risk for the development of snoring problems. As per American Lung Association, average smoker smokes 15 cigarettes per day in the US. Similar trends can be observed in other countries of Europe and in China and Australia. As per Institute of Health Metrics and Evaluation (IHME) Organization, there were around 2.6 million deaths in the year 1990 combinedly in the US, the UK, India, China, Germany and Canada due to smoking of tobacco. In 2016, it was estimated to be 3.2 million mortalities due to smoking in the following countries. Rising such activities contribute to the growth of the market as smoking increase the risk of snoring by causing inflammation along the tissues with the smoke from cigarettes and cigars.
Global anti-snoring treatment market can be segmented on the basis of device, and surgery. According to the device, the market is further diversified as mandibular advancement devices, nasal devices, continuous positive airway pressure devices, and others. Among devices, continuous positive airway pressure (CPAP) devices segment is anticipated to hold the significant share as it is the most commonly used treatment among children and adults. In addition, CPAP devices are the most preferred devices for anti-snoring treatment by physicians and doctors. As per surgery, the market is further sub-segmented as uvulopalatopharyngoplasty, radiofrequency ablation, laser-assisted uvulopalatoplasty, and others such as pillar procedures. Uvulopalatopharyngoplasty among all is a cost-effective surgery and is estimated to contribute significantly in the market.
Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is expected to contribute considerably to the global anti-snoring treatment market owing to increasing demand from sleep apnea patients in the region. In addition, economies such as the US and Canada are contributing significantly to the growth of anti-snoring treatment in the North American region.
There are various companies that are involved in the global anti-snoring treatment market such as Medtronic PLC, Invacare Corp., Koninklijke Philips NV, Oventus Medical Ltd., ResMed Inc., and others. To stay competitive in the market, the players in the market adopt various strategies such as partnership and collaboration, and product launch. For instance, ResMed Inc., in May 2017, launched AirTouch F20 full face mask for patients on CPAP therapy for sleep apnea. It features an UltraSoft memory foam mask cushion for ensuring enhanced patient comfort.
Research Methodology
The market study of the global anti-snoring treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include
The report is intended for anti-snoring treatment device manufacturing and selling companies, e-commerce companies, government organization, venture capitalists for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, growth opportunities, and different products. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation
Global anti-snoring treatment market is segmented on the basis of regional outlook and following segments:
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Koninklijke Philips N.V.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Invacare Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Oventus Medical Ltd.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. ResMed Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Anti-Snoring Treatment Market by Device
5.1.1. Mandibular Advancement Devices
5.1.2. Nasal Devices
5.1.3. Continuous Positive Airway Pressure (CPAP) Devices
5.1.4. Others (Tongue Stabilizing Devices)
5.2. Global Anti-Snoring Treatment Market by Surgery
5.2.1. Uvulopalatopharyngoplasty (UPPP)
5.2.2. Radio-frequency Ablation (Somnoplasty)
5.2.3. Laser-assisted uvulopalatoplasty (LAUP)
5.2.4. Others (Pillar Procedure)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3B Medical, Inc.
7.2. Aeroflow, Inc.
7.3. Apnea Sciences Corp.
7.4. Asclepion Laser Technologies GmbH
7.5. BMC Medical Co., Ltd.
7.6. Curative Medical, Inc.
7.7. Goodsomnia AB
7.8. Invacare Corp.
7.9. Koninklijke Philips N.V.
7.10. Meditas, Ltd.
7.11. Medtronic PLC
7.12. Oventus Medical, Ltd.
7.13. ResMed, Inc.
7.14. SleepNet Corp.
7.15. SomnoMed, Inc.
7.16. The Pure Sleep Co.
7.17. Tomed GmbH
7.18. Whole You, Inc.
7.19. Zelegent, Inc.
LIST OF TABLES
TABLE # 1 GLOBAL ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY DEVICE, 2018-2025 ($ MILLION)
TABLE # 2 GLOBAL MANDIBULAR ADVANCEMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 3 GLOBAL NASAL DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 4 GLOBAL CPAP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 5 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 6 GLOBAL ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY SURGERY, 2018-2025 ($ MILLION)
TABLE # 7 GLOBAL UPPP MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 8 GLOBAL RADIOFREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 9 GLOBAL LAUP MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 10 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
TABLE # 11 GLOBAL ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
TABLE # 12 NORTH AMERICAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 13 NORTH AMERICAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY DEVICE, 2018-2025 ($ MILLION)
TABLE # 14 NORTH AMERICAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY SURGERY, 2018-2025 ($ MILLION)
TABLE # 15 EUROPEAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 16 EUROPEAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY DEVICE, 2018-2025 ($ MILLION)
TABLE # 17 EUROPEAN ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY SURGERY, 2018-2025 ($ MILLION)
TABLE # 18 ASIA-PACIFIC ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
TABLE # 19 ASIA-PACIFIC ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY DEVICE, 2018-2025 ($ MILLION)
TABLE # 20 ASIA-PACIFIC ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY SURGERY, 2018-2025 ($ MILLION)
TABLE # 21 REST OF THE WORLD ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY DEVICE, 2018-2025 ($ MILLION)
TABLE # 22 REST OF THE WORLD ANTI-SNORING TREATMENT MARKET RESEARCH AND ANALYSIS BY SURGERY, 2018-2025 ($ MILLION)
LIST OF FIGURES
FIGURE # 1 GLOBAL ANTI-SNORING TREATMENT MARKET SHARE BY DEVICE, 2018 VS 2025 (%)
FIGURE # 2 GLOBAL ANTI-SNORING TREATMENT MARKET SHARE BY SURGERY, 2018 VS 2025 (%)
FIGURE # 3 GLOBAL ANTI-SNORING TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
FIGURE # 4 US ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 5 CANADA ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 6 UK ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 7 FRANCE ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 8 GERMANY ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 9 ITALY ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 10 SPAIN ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 11 ROE ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 12 INDIA ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 13 CHINA ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 14 JAPAN ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
FIGURE # 16 REST OF THE WORLD ANTI-SNORING TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)